C3a/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy
International Journal of Molecular Medicine · 14.10.2025 · 56 (6) · 1-15
DOI: 10.3892/ijmm.2025.5664 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 14.10.2025. Verfasst von Mengjie Weng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350005, P.R. C…. Hauptthemen laut MEDLINE: Podocytes, Diabetic Nephropathies, Mitophagy, Complement C3a. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The C3a/C3aR axis has been confirmed to be associated with the pathogenesis of diabetic nephropathy (DN) and mitochondrial dysfunction; however, the exact mechanisms underlying its role in diabetic podocytopathy remain unclear. The present study investigated the involvement of C3a/C3aR signaling in regulating mitophagy during the progression of DN. Diabetic db/db mice exhibited elevated renal C3 and C3aR levels, concurrent with podocyte injury, proteinuria and glomerular damage. Administration of the C3aR antagonist (C3aRA) SB290157 attenuated podocyte loss, reduced albuminuria and mitigated glomerular pathology. Ultrastructural and functional analyses revealed that C3aRA restored mitochondrial integrity in podocytes, resolving diabetes‑associated fragmentation and bioenergetic deficits. In vitro, high glucose‑exposed human podocytes displayed suppressed mitophagy and mitochondrial dysfunction, which were exacerbated by exogenous C3a. Conversely, C3aRA treatment enhanced mitophagy and preserved mitochondrial membrane potential, while small interfering RNA‑mediated C3aR or PINK1 knockdown abolished these protective effects. Notably, C3aRA activated the PI3K/AKT/FoxO1 pathway, driving both mitochondrial biogenesis and mitophagy. Disruption of this axis via FoxO1 inhibition reversed the therapeutic benefits of C3aRA, confirming its mechanistic centrality. In conclusion, the C3a/C3aR/PI3K/AKT/FoxO1 axis represents a previously unrecognized molecular bridge between complement activation and mitophagy failure in DN. Pharmacological disruption of this pathway could preserve podocyte homeostasis, offering a precision strategy against diabetic kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Zitieren
APA
Weng, M., Wu, X., Rao, S., Nie, K., You, D., Zheng, T., Lin, E., Zheng, J., Cui, J., & Wan, J. (2025). C3a/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy. International Journal of Molecular Medicine, 56(6), 1-15. https://doi.org/10.3892/ijmm.2025.5664
Vancouver
Weng M, Wu X, Rao S, Nie K, You D, Zheng T, et al. C3a/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy. International Journal of Molecular Medicine. 2025;56(6):1-15. doi:10.3892/ijmm.2025.5664
BibTeX
@article{Weng2025,
author = {Weng, Mengjie and Wu, Xiaoting and Rao, Siyi and Nie, Kun and You, Danyu and Zheng, Tingting and Lin, Enqin and Zheng, Jing and Cui, Jiong and Wan, Jianxin},
title = {C3a/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy},
journal = {International Journal of Molecular Medicine},
year = {2025},
volume = {56},
number = {6},
pages = {1--15},
doi = {10.3892/ijmm.2025.5664}
}
EUVIMED